APA

Ramalingam S. S., Yang J. C., Lee C. K., Kurata T., Kim D., John T., Nogami N., Ohe Y., Mann H., Rukazenkov Y., Ghiorghiu S., Stetson D., Markovets A., Barrett J. C., Thress K. S. & Jänne P. A. (20190802). Osimertinib As First-Line Treatment of EGFR Mutation-Positive Advanced Non-Small-Cell Lung Cancer. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chicago

Ramalingam Suresh S, Yang James C-H, Lee Chee Khoon, Kurata Takayasu, Kim Dong-Wan, John Thomas, Nogami Naoyuki, Ohe Yuichiro, Mann Helen, Rukazenkov Yuri, Ghiorghiu Serban, Stetson Daniel, Markovets Aleksandra, Barrett J Carl, Thress Kenneth S and Jänne Pasi A. 20190802. Osimertinib As First-Line Treatment of EGFR Mutation-Positive Advanced Non-Small-Cell Lung Cancer. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Harvard

Ramalingam S. S., Yang J. C., Lee C. K., Kurata T., Kim D., John T., Nogami N., Ohe Y., Mann H., Rukazenkov Y., Ghiorghiu S., Stetson D., Markovets A., Barrett J. C., Thress K. S. and Jänne P. A. (20190802). Osimertinib As First-Line Treatment of EGFR Mutation-Positive Advanced Non-Small-Cell Lung Cancer. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

MLA

Ramalingam Suresh S, Yang James C-H, Lee Chee Khoon, Kurata Takayasu, Kim Dong-Wan, John Thomas, Nogami Naoyuki, Ohe Yuichiro, Mann Helen, Rukazenkov Yuri, Ghiorghiu Serban, Stetson Daniel, Markovets Aleksandra, Barrett J Carl, Thress Kenneth S and Jänne Pasi A. Osimertinib As First-Line Treatment of EGFR Mutation-Positive Advanced Non-Small-Cell Lung Cancer. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 20190802.